webjb

伊维霉素+mebendazole的临床试验:48%的癌症或消失

送交者: testtesttest 于 2026-04-08 02:16:46

回答: 露头社的报道由于 2026-04-08 00:23:57

或Regression
------------------------

BREAKING: Largest Real-World Analysis of Ivermectin + Mebendazole in Cancer Patients Shows 84.4% Clinical Benefit — Nearly HALF Report Cancer Disappearance or Regression

After just 6 months, 48.4% of cancer patients taking ivermectin and mebendazole reported no evidence of disease (32.8%) or tumor regression (15.6%), while 36.1% reported disease stabilization.

Nicolas Hulscher, MPH
Apr 07, 2026

https://www.thefocalpoints.com/p/breaking-largest-real-world-analysis

阅读次数：63

所有跟贴:

加跟贴